Tag:
dermatology
Latest Headlines
Latest Headlines
Sol-Gel seals $27M dermatology drug delivery deal with mystery partner
Israeli pharmaceutical company Sol-Gel Technologies says it nailed down a $27 million development and licensing deal with an as-yet unnamed U.S. pharmaceutical company regarding a "major"...
Valeant aims for top of dermatology, CEO says
No, you don't have double vision. Valeant Pharmaceuticals ( $VRX ) did buy two dermatology operations last week. First came Sanofi's ( $SNY ) Dermik unit, which Valeant agreed to acquire for $425
Sanofi taking bids for dermatology franchise
Dermatology drugs aren't growing fast enough. At least not in Sanofi-Aventis' opinion. The company is looking at selling off its U.S. dermatology business, collecting bids for a deal that could be
Stanford team (briefly) reverses skin aging
Blocking a single critical protein reversed the effects of aging on the skin of mice, suggesting that researchers may be on to a short-term therapy that could help older people heal from an injury.
Researchers find cause, therapies for rosacea
Researchers have solved the centuries-old riddle regarding the causes rosacea. In doing so, they have also outlined a clear path for the first effective treatments to cure the splotchy skin patches
